Serum osteocalcin in the management of myeloma
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (1) , 140-142
- https://doi.org/10.1016/0959-8049(93)90593-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Decreased Serum Osteocalcin Levels in Phenprocoumon-Treated PatientsJournal of Clinical Endocrinology & Metabolism, 1988
- Circulating Osteocalcin During Oral Anticoagulant TherapyThrombosis and Haemostasis, 1988
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987
- Effect of Renal Function on Plasma Levels of Bone Gla-Protein*Journal of Clinical Endocrinology & Metabolism, 1983
- Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple MyelomaBritish Journal of Haematology, 1981
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- The determination of hydroxyproline in urine hydrolysatesClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- A Staining Method for Proteins and Dextrans on Cellulose AcetateNature, 1965